Table 5.

Additional medication for symptom relief and limitation of activity during the treatment

Additional comparison	Time	Conventional nebulization N (%)	Smart nebulization N (%)	Total N (%)	P-value
Additional medication for symptom relief	During 1st week	1 (2.86)	1 (3.33)	2 (3.08)	1.000
	During 4th week	2 (5.71)	0 (0.00)	2 (3.08)	0.495
	During 8th week	1 (2.86)	1 (3.33)	2 (3.08)	1.000
	During 12th week	5 (14.29)	2 (6.67)	7 (10.77)	0.437
Activity limitation	During 1st week	0 (0.00)	3 (10.00)	3 (4.62)	0.093
	During 4th week	0 (0.00)	1 (3.33)	1 (1.54)	0.462
	During 8th week	0 (0.00)	1 (3.33)	1 (1.54)	0.462
	During 12th week	1 (2.86)	1 (3.33)	2 (3.08)	1.000